{
    "nctId": "NCT00884143",
    "briefTitle": "Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer",
    "officialTitle": "Retrospective Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer in Two Successive Time Periods",
    "overallStatus": "COMPLETED",
    "conditions": "Post Menopausal, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 515,
    "primaryOutcomeMeasure": "Relative frequencies of the first adjuvant hormonal treatment (tamoxifen vs aromatase inhibitor) started during two time periods of 12 months each - the years 2006 and 2008",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Post-menopausal patients with surgically treated breast cancer who started adjuvant hormonal therapy between January 2006 and December 2006 or between January 2008 and December 2008\n* Documented evidence of the way adjuvant hormonal treatment was initiated.\n\nExclusion Criteria:\n\n* Pre- or peri-menopausal patients with surgically treated breast cancer who started adjuvant hormonal therapy\n* Patients already enrolled in clinical studies aimed at investigating hormone therapies",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}